Coeptis Therapeutics pursuing possible acquisition of cell therapy platform
March 29, 2023 at 14:06 PM EDT
Coeptis did not offer a timeline as to when it expects to conclude its due diligence analysis, which has since begun.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following